Disc Medicine Inc (IRON)
followers
ยท
Follow
Sector: | HEALTH CARE |
Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
SIC: | PHARMACEUTICAL PREPARATIONS |
CEO: | Georges Gemayel |
Employees: | 30 |
Web site: | geminitherapeutics.com |
321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
(617) 674-9274
|
Are you looking for this stock instead?
Date | Ratio |
---|---|
2022-12-30 | 1:30 |
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
Gemini Therapeutics, Inc. engages in developing therapeutic compounds for treating genetically defined age-related macular degeneration (AMD) Its lead candidate is GEM103, a recombinant form of the human complement factor H protein. The company also develops GEM307 for treatment of systemic diseases.
Please log in first to see chart